Technological development in health care leads to new processes and products aiming at improving diagnoses and therapies of diseases. Whether these are successfully introduced depends on aspects such as effectiveness and costs of the new processes and products, the way institutions support or hinder introductions and the processes of integration into health care systems. Over 90 percent of the German population are compulsory members of the public health insurance system. Here, contributions to the system are incomebased and patients receive benefits-in-kind from the catalogue of services. The remaining 10 percent receive medical services according to a contract and are entitled to a reimbursement of their medical bills ...